Search

Hikma Pharmaceuticals PLC

Gesloten

SectorGezondheidszorg

1,596 -0.87

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1594

Max

1626

Belangrijke statistieken

By Trading Economics

Inkomsten

56M

221M

Verkoop

15M

1.7B

K/W

Sectorgemiddelde

12.454

56.659

Dividendrendement

5.32

Winstmarge

12.905

Werknemers

9,500

EBITDA

67M

478M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+15.11% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

5.32%

2.18%

Volgende dividenddatum

17 sep 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

64M

3.4B

Vorige openingsprijs

1596.87

Vorige sluitingsprijs

1596

Nieuwssentiment

By Acuity

6%

94%

4 / 340 Rangschikking in Healthcare

Hikma Pharmaceuticals PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 sep 2026, 23:56 UTC

News

Entergy Corp settled its 2025 forward sale agreements, delivering over 11 million shares for $913 million. Shares are higher in after-market trading.

2 sep 2026, 23:51 UTC

News

Mitek Systems Inc. won first place in the Image category of the 2026 LivDet-Face competition, boosting shares significantly higher in after-hours trading.

2 sep 2026, 23:51 UTC

News
Social Media

Uber Technologies Inc. shares are higher in after-market hours following its abrupt exit from Nigeria and plans to lay off over 3,000 employees globally.

2 sep 2026, 23:51 UTC

News

Revolution Medicines shares rise in after-market trading following positive Phase 1/2 data on RASONQUE for advanced RAS mutant non-small cell lung cancer.

2 sep 2026, 23:51 UTC

News

NWPX Infrastructure acquires Serpentix Conveyor, enhancing its wastewater treatment portfolio. Shares are trading higher in after-market hours following the announcement.

2 sep 2026, 23:46 UTC

News
Social Media

Zoom Communications appoints Jeff Epstein to its Board of Directors, effective immediately. Shares are trading higher in after-market hours amid leadership changes.

2 sep 2026, 23:41 UTC

News
Correlated Moves

nCino Inc will participate in the Piper Sandler Growth Frontiers Conference on September 16, 2026. Shares are higher in after-market trading.

2 sep 2026, 23:36 UTC

News

Phreesia shares declined after reporting second-quarter revenues of $129.5 million, while earnings per share of $0.03 missed expectations of $0.09.

2 sep 2026, 23:31 UTC

News

Genworth Financial announced a $500 million share repurchase program, with shares trading higher in after-market hours.

2 sep 2026, 23:31 UTC

News

Capital Southwest Corp increased its credit facility commitments to $595 million and extended the maturity to September 2031. Shares are higher in after-market trading.

2 sep 2026, 23:26 UTC

News

Sprinklr Inc shares are higher in after-market trading ahead of a meeting with DA Davidson on September 10, signaling potential strategic discussions.

2 sep 2026, 23:16 UTC

News
Correlated Moves

Cytokinetics Inc shares are trading lower after-market following its investor conference announcements, with Ionis Pharmaceuticals' decline possibly impacting sentiment in the sector.

2 sep 2026, 23:06 UTC

News
Social Media

JPMorgan Chase has reduced financing to Jane Street amid competition in the bond market, with shares trading near unchanged in after-market hours.

2 sep 2026, 23:06 UTC

News

Johnson & Johnson will participate in the Deutsche Bank 2026 Healthcare Summit on September 17. Shares are higher in after-market trading following the announcement.

2 sep 2026, 23:06 UTC

News
Correlated Moves

The U.S. Justice Department disrupted the Sality botnet, linked to cryptocurrency theft, contributing to CrowdStrike's higher shares in after-market hours.

2 sep 2026, 23:02 UTC

News
Social Media
Event

Broadcom Inc. shares fell in after-market trading following third-quarter earnings. Fourth-quarter revenue guidance of $34.8 billion missed consensus expectations of $35.05 billion.

2 sep 2026, 23:02 UTC

News

C3.ai Inc reported a fiscal Q1 net loss of $92.8 million and projected second-quarter revenue below expectations, contributing to a decline in after-market hours.

2 sep 2026, 23:02 UTC

News
Event
Social Media

Five Below Inc. shares rose in after-market trading after strong Q2 earnings and a $600 million share repurchase program announcement. Revenue guidance was also raised.

2 sep 2026, 23:02 UTC

News
Social Media

Ultragenyx Pharmaceutical shares are lower in after-market hours following the failure of its Phase 3 Aspire study for apazunersen in Angelman syndrome.

2 sep 2026, 23:02 UTC

News
Social Media

Snowflake Inc's stock rose in after-market trading following strong Q2 results, with adjusted EPS of $0.62 and revenue of $1.55 billion exceeding expectations.

2 sep 2026, 23:02 UTC

News

Kroger Co shares traded lower in after-market hours following the appointment of Mark Ibbotson as Executive Vice President and Chief Store Operations Officer.

2 sep 2026, 23:02 UTC

News
Social Media

NetApp Inc. shares declined in after-market trading following its earnings report, despite record revenues of $2.03 billion and raised fiscal year 2027 guidance.

2 sep 2026, 23:02 UTC

News

Ollie's Bargain Outlet updated its fiscal year 2026 EPS guidance, projecting $4.570 to $4.650, exceeding the consensus estimate. Shares are higher in after-market trading.

2 sep 2026, 23:01 UTC

News
Social Media

AeroVironment secures a $464.8 million U.S. Army contract for laser systems, boosting after-market shares amid positive revenue growth projections of $2.7 billion by 2028.

2 sep 2026, 23:01 UTC

News

Mirion Technologies shares rose in after-market trading following CFO Brian Schopfer's purchase of 20,000 shares for $312,000, increasing his total ownership to 1.33 million shares.

2 sep 2026, 23:01 UTC

News

Matrix Service Co's stock is lower in after-market hours following a fourth-quarter earnings miss, with adjusted EPS at $0.16 against a $0.20 estimate.

2 sep 2026, 23:01 UTC

News

Argan Inc reported record revenue of $384 million and net income of $53.3 million in Q2, driving shares sharply higher in after-market hours.

2 sep 2026, 23:01 UTC

News
Social Media
Event

PVH Corp reported second-quarter adjusted EPS of $3.70, exceeding expectations. Shares are trading higher in after-market hours following the earnings announcement.

2 sep 2026, 23:01 UTC

News
Social Media

Methode Electronics reported a wider net loss of $11.4 million for Q1 fiscal 2027, leading shares to trade lower in after-market hours.

2 sep 2026, 23:01 UTC

News
Event
Social Media

Tillys Inc shares rose in after-hours trading following strong Q2 results, with EPS of $0.27 surpassing estimates and revenue of $163.5 million.

Peer Vergelijking

Prijswijziging

Hikma Pharmaceuticals PLC Prognose

Koersdoel

By TipRanks

15.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 1,859 GBX  15.11%

Hoogste 2,100 GBX

Laagste 1,350 GBX

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Hikma Pharmaceuticals PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

4

Buy

0

Hold

1

Sell

Sentiment

By Acuity

4 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat